Secrets For Saving On Medications
September 1, 2010 by WUSA9
Filed under Mail Service Pharmacy, Managing My Drug Costs, Top Headlines
Americans spend a fortune every year on prescription drugs, $300 billion in 2009 alone. Now that times are tough, some consumers have stopped taking certain medications in order to save money.Angie’s List founder Angie Hicks says there are better options, such as enlisting a doctor to help control costs. Hicks recommends [...]
AARP Report Fuels Debate Over Drug Pricing; AHIP, PHRMA, NCPA And PCMA Join In
August 26, 2010 by Inside Health Policy, Amy Lotven
Filed under Legislation / Policy, Top Headlines
A new report by AARP’s Public Policy Institute, which concluded that prices for Medicare’s most commonly used brand-named drugs dramatically increased in 2009, has prompted debate among several players in the health care sector. An insurance industry source says AARP’s finding that drug prices increased by 8.3 percent in 2009 is [...]
More Than a Quarter of Prescription Takers Cut Corners to Save Money
August 25, 2010 by The Wall Street Journal Health Blog
Filed under Generics, Managing My Drug Costs, Top Headlines
More than a quarter of Americans who take prescription drugs have skipped doses, split pills or cut other corners to save money in the last year, according to a new study by Consumer Reports.
(The survey also asked prescription-drug users what they thought about the pharma industry’s influence [...]
Lower Your Prescription-Drug Costs
August 25, 2010 by Kiplinger, Kimberly Lankford
Filed under Generics, Mail Service Pharmacy, Managing My Drug Costs, Top Headlines
These three strategies will help you save money when you’re in the Medicare Part D doughnut hole.
I reached the doughnut hole for my Medicare Part D plan, and now I have to pay for all of my drugs myself. How can I lower my costs for my medications?
One of the toughest things about Medicare Part [...]
AARP Says Brand-Name Drug Prices Up 8% in 2009
August 25, 2010 by The New York Times, Duff Wilson
Filed under Generics, Legislation / Policy, Top Headlines
A new report on retail prices of brand-name drugs shows the 217 products most used by older Americans increased by an average of 8.3 percent during 2009, the largest increase in years, even as inflation was negative.
Over the last five years, according to the report to be released on [...]
Bills would ban drugmaker deals to delay cheap drugs
August 18, 2010 by USA Today
Filed under Top Headlines
Generic-drug makers in the past year have dropped a record number of patent lawsuits against brand-name pharmaceutical companies in exchange for compensation to delay getting money-saving drugs to market.
Legislation that has recently gained momentum in Congress threatens to end such deals.
The House has passed a bill limiting [...]
How to Keep the Cost of Prescription Drugs Down
August 9, 2010 by FOX Business, Barbara Mannino
Filed under Managing My Drug Costs, Top Headlines
The health-reform law helps reduce prices on drug costs, but there are steps you can take further reduce costs.
Sticker shock at the pharmacy window has resulted in increased public pressure to stem drug costs.
Experts agree the health-care reform bill provides some cost savings for the average consumer now, and [...]
5 Generic Products That Are Just as Good
August 9, 2010 by Yahoo Finance, Amy Bell
Filed under Generics, Managing My Drug Costs, Top Headlines
In today’s tough economy, consumers are pinching pennies by choosing generic over big name brands in their supermarket aisles. From chips and dips to pain relievers and peanut butter, there’s a cheaper generic version of almost every product.
Of course, some of these no-name products are second-rate. For [...]
Controversial ‘Pay For Delay’ Provision Attached To Financial Services Bill
July 28, 2010 by Inside Health Policy, Amy Lotven
Filed under Top Headlines
Controversial legislation that would limit brand-name and generic drug makers from reaching deals to delay generic drug marketing was attached to a Senate appropriations subcommittee’s financial services spending bill on Tuesday, sources say. The measure has been briefly attached to several other bills over the past year, including health reform legislation, only to be dropped [...]
US sees jump in “pay-for-delay” drug settlements
July 28, 2010 by Reuters
Filed under Top Headlines
Brand-name drug companies made a record 21 deals so far this fiscal year with generic firms that delayed production of cheaper generic drugs, the U.S. Federal Trade Commission told lawmakers on Tuesday.
The FTC is trying to crack down on so-called “pay-for-delay” settlements, highlighting that when generic versions [...]